In the context of cancer, the immune repertoire plays a critical role in identifying and attacking cancer cells. Cancer cells often express unique antigens, known as tumor-associated antigens or neoantigens, which can be recognized by the immune system. A diverse immune repertoire increases the likelihood that the immune system can identify and mount an effective response against these antigens.
